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Abstract Pain is one of the most 
common symptoms experienced the 
world over. It has always received 
the needed attention and care in the 
adult but not until recently among 
children. Several erroneous beliefs 
contributed to the inadequate atten-
tion among children such as as-
sumption that children did not ex-
perience pain to the extent that 
adults do, because of the immature 
nervous system, or that children 
would not remember the pain. A 
paediatrician is expected to be 
knowledgeable about pediatric pain 
management principles, provide a 
calm environment for painful proce-
dures, use appropriate assessment 
tools and techniques, anticipate 
painful experiences, use a multimo-
dal approach (pharmacologic, cog-
nitive, behavioral, and physical) to 
pain management, use a multidisci-
plinary approach when possible  
and involve families in creating 
solutions for their child’s pain. 
Studies have shown that the most 
common reason for unrelieved pain 
is failure to routinely assess pain 
and provide pain relief. The theo-
ries, pathways, transmission, regu-
lations, classifications, assessment 
scales and the treatment of paediat-
ric pain and practical issues that 
arise from the use of pharmacologic 
analgesic in the children were also  
reviewed and highlighted.   
 




Pain is a ubiquitous aspect of human experience and 
epitomizes human suffering. Historically, we have done 
a poor job of addressing pain especially in children.  
In 1979 IASP defined pain as “unpleasant sensory and 
emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage.”  
Pain from poena-latin means punishment.  
 
Pain is an unpleasant feeling that is conveyed to the 
brain by sensory neurons. The discomfort signals actual 
or potential injury to the body. Perception gives 
information on the pain's location, intensity, and 
something about its nature.  
 
Historical perspective: Several theories proposed 
Straight channel theory: In 1644 Descartes proposed a 
theory of pain exits from the skin to the brain. During 
the 19th century, Von Frey theorized that pain pathways 
move from specialized receptors in body tissues to a 
pain center in the brain. 
  
Specificity theory: Based on the presence of specialized 
peripheral receptors rather than a central mechanism of 
pain in the brain. This does not explain the phenomenon 
of phantom limb pain when peripheral receptors no 
longer exist. 
 
Pattern theory: Proposed in the late 19th century. Pain 
is the result of stimulation of certain nerve impulses that 
form a pattern, combine and then dumped into the spinal 
cord as a lump sum of pain, a process called central 
summation. However this theory does not account for 
other factors of pain perception, such as the effect of 
placebos on pain. 
 
Gate control theory: In 1965, Melzack and Wall pub-
lished the gate control theory of pain. A mechanism n 
the brain acts as a gate to increase or decrease the flow 
of nerve impulses from the peripheral fibres to the cen-
tral nervous system. An “open” gate allows the flow f 
nerve impulses, and the brain can perceive pain. A 
“closed” gate does not allow flow of nerve impulses, 
decreasing the perception of pain. Although the gate 
control theory has been widely accepted since the 1970s, 
it leaves unanswered questions, including chronic pain 
issues, sex-based differences, stress effects, and the ef-
fects of previous pain experiences. 
 
Neuromatrix theory: In 1999, Melzack and Wall pre-
sented a newer theory of pain, consistent with the idea of 
gate control that addresses some of these unanswered 
questions. This “new and improved” theory, the neuro-
matrix theory, says that each person has a genetically 
built-in network of neurons called the “body-self neuro-
matrix. Just as each person is unique in physical appe r-
ance, each person’s matrix of neurons is unique and is 
affected by all facets of the person’s physical, psycho-
logical, and cognitive makeup, as well as his or her ex-
perience. Thus, the pain experience does not reflect a 
simple one-to-one relationship between tissue damage 
and pain. 
 
Pain Pathways and Transmission 
 
 Previously, pain pathways were seen as having three 
components:-  
• A first order neurone (cell body in dorsal root 
ganglion) which transmits pain from a peripheral 
receptor.  
• A second-order neurone in the dorsal horn of the 
spinal cord, which axon crosses the midline to 
ascend in the spinothalamic tract to the thalamus.  
• A third-order neurone projects to the postcentral 
gyrus (via the internal capsule).  
 
This scenario, while partially correct, is now known to 
be horribly over-simplified. The pathways that carry 
information about noxious stimuli to the brain, as might 
be expected for such an important and multifaceted 
system, are complex. The major pathways are 
summarized in the following figure which omits some of 
the less well understood subsidiary routes. Because 
projections from non-nociceptive temperature-sensitive 
neurons follow the same anatomical route, they are 
included in this description, even though they are not 
part of the pain system. Nociceptors, or pain receptors, 
are free nerve endings that respond to painful stimuli. 
Nociceptors are found throughout all tissues except the 
brain, and they transmit information to the brain.  They 
are stimulated by biological, electrical, thermal, 
mechanical, and chemical stimuli. Pain perception 
occurs when these stimuli are transmitted to the spinal 
cord and then to the central areas of the brain.  Pain 
impulses travel to the dorsal horn of the spine, where 
they synapse with dorsal horn neurons in the substantia 
gelatinosa and then ascend to the brain. 
 
Two types of fibers are involved in pain transmission:  
The large A delta fibers produce sharp well-defined 
pain, called “fast pain” or “first pain,” typically stimu-
lated by a cut, an electrical shock, or a physical blow. 
Transmission through the A fibers is so fast that the
body’s reflexes can actually respond faster than the pain 
stimulus, resulting in retraction of the affected body part 
even before the person perceives the pain. 
 
After this first pain, the smaller C fibers transmit dull 
burning or aching sensations, known as “second pain.” 
The C fibers transmit pain more slowly than the A fibers 
do because the C fibers are smaller and lack a myelin 
sheath. The C fibers are the ones that produce constant 
pain. According to the gate control theory, stimulation 
of the fibers that transmit non-painful stimuli can block 
pain impulses at the gate in the dorsal horn.  For exam-
ple, if touch receptors (A beta fibers) are stimulated, 
they dominate and close the gate. This ability to block 
pain impulses is the reason a person is prone to immedi-
ately grab and massage the foot when he or she stubs a 
toe. The touch blocks the transmission and duration of 
pain impulses. Since the mechanosensory pathway as-
cends ipsilaterally in the cord, a unilateral spinal lesion 
will produce sensory loss of touch, pressure, vibration, 
and proprioception below the lesion on the same sid. 
The pathways for pain and temperature, however, cross 
the midline to ascend on the opposite side of the cord. 
This pattern is referred to as a dissociated sensory loss 
and (together with local dermatomal signs; helps define 
the level of the lesion. 
 
Regulators of Pain 
 
Chemical substances that modulate the transmission of 
pain are released into the extracellular tissue when tissue 
damage occurs. They activate the pain receptors by irri-
tating nerve endings. These chemical mediators include 
histamine, substance P, bradykinin, acetylcholine, leu-
kotrienes and prostaglandins. The mediators can produce 
other reactions at the site of injury, such as vasoconstric-
tion, vasodilatation, or altered capillary permeability. 
For example, prostaglandins induce inflammation and
potentiate other inflammatory mediators. Aspirin a on-
steroidal anti inflammatory medications, and the new 
cyclooxygenase-2 (COX-2) inhibitors block cyclooxy-
genase-2, the enzyme needed for prostaglandin synthe-
sis, thus reducing pain.  Consequently, these medica-
tions are often prescribed for painful conditions due to 
inflammation. 
 
Fibers in the dorsal horn, brain stem, and peripheral tis-
sues release neuromodulators, known as endogenous 
opioids that inhibit the action of neurons that transmit 
pain impulses. β-endorphins and dynorphins are types of 
natural opioid-like substances released, and they ar  
responsible for pain relief. Endorphins are the modula-
tors that allow an athlete to continue an athletic vent 
after sustaining an injury. Endorphin levels vary fom 
person to person, so different persons experience differ-
ent levels of pain. This endogenous opioid mechanism 
may play an important role in the placebo effect.  A pla-
cebo is an inactive substance or treatment used for com-
parison with “real” treatment in controlled studies to 
determine the efficacy of the treatment under study. De-
spite the lack of any intrinsic value, placebos canand do 
produce an analgesic response in many persons. Placebo 
analgesia can affect nociceptive mechanisms in the cor-
tex of the brain and descending pathways of the spinal 
cord. 
 
Classification of Pain 
 
 Pain can be divided into 
(A) nociceptive (B) neuropathic (C) a mixture of these 
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two types. Pain can also be divided into acute or 
chronic.   
 
Nociceptive pain: In this type of pain, so-called 
‘nociceptors’ play a central role. Nociceptors are th  
receptors of sensory neurons that are located in the skin, 
mucosa or internal organs. Pain arises when these 
receptors are activated by a possibly damaging stimulus.  
Different types of nociceptors perceive different types of 
stimuli, and these include; thermal nociceptors activated 
by noxious heat or cold; mechanical nociceptors notice 
excess pressure or deformation;chemical nociceptors are 
sensitive to chemical substances.  
 
Nociceptive pain can be further divided according to the 
part of the body into: Somatic pain which originates 
from bones, muscles, tendons or blood vessels and is 
often known as musculo-skeletal pain, usually sharp, 
well-localized can be reproduced by touching or moving 
the involved area usually of longer duration. Cutaneous 
pain is due to injury of the skin or the superficial t ssues 
usually well-described, localised pain of short duration 
e.g. paper cut, minor burns.Visceral pain originates from 
the internal organs of the body’s cavities such as thorax 
(heart and lungs), abdomen (liver, kidneys, spleen and
bowels) and pelvis (ovaries, bladder and womb). 
Visceral pain is more aching, vague and often difficult 
to localise, usually of longer duration sometimes colicky 
or cramping such as gastro-intestinal spasms.  
 
Neuropathic pain: This pain type follows damage to 
the central or peripheral nervous system. There are no 
specific receptors involved and pain is generated by 
nerve cell dysfunction. Chronic, often intractable pain 
due to injury to the peripheral nerves is known as 
neuropathic pain. According to Devor and Seltzer, this
pain is a paradox. Injury to peripheral nerves should 
deaden sensation, much as cutting a telephone wire 
leaves the phone line dead, but the opposite occurs in 
neuropathic pain. Injury to the peripheral nerves can 
cause spontaneous paresthesias, numbness, pain with 
movement, tenderness of a partly denervated part and 
pain that is electric shock–like, burning, shooting, or 
tingling. Types of neuropathic pain include- 
 
• Peripheral neuropathy: means that the peripheral 
nerves are not working properly. It is usually the 
result of an injury to or a disease process, such as 
diabetes associated with loss of function in the 
nerve. Often starts in the hand and feet, and tends to 
affect the body symmetrically.  
• Entrapment of  nerve: pinched or trapped nerve 
due to compression in the spine or elsewhere in the 
body, such as elbow, shoulder, wrist or foot.  
• Phantom limb pain: sensation of pain from a limb 
that has been lost or from which no longer physical 
signals are being received, reported after 
amputation or in quadriplegics.  
• After amputation of a limb, a patient may experi-
ence painful sensations in the missing limb. As 
many as 70% of amputees report this phantom limb 
pain, and usually within the first week after  
        amputation. 
• Chronic central neuropathic pain: can follow 
traumatic spinal cord injury or diseases of the brain 
itself, like stroke.  
• Other causes  
 
 Mixed pain: In this type of pain both nociceptive and 
neuropathic pain mechanisms are involved. For instance 
in cancer pain, the pain can be due to the tumour causing 
inflammation of tissue around the tumour (nociceptive) 
and causing entrapment of a nerve (neuropathic). Also 
chronic low back pain is often a combination of 
nociceptive and neuropathic pain. The back itself may 
hurt with a constant aching (nociceptive pain) and there 
may be additionally sudden burning and hurting 
sensations extending into the legs, which are called 
sciatiae and are of neuropathic origin.  
 
Other classifications include 
 
Acute Pain: Everyone have experienced acute pain. Bee 
stings, bumped knees, and bone fractures are simple 
examples. Most acute pain serves a clear purpose: sme
problem needs to be addressed It is practically 
automatic. Acute pain is characterized by help-seeking 
behavior. In most cases people cry out and move about 
in a very obvious manner. Physiologic responses to 
acute pain include tachycardia, tachypnea, and sweating 
due to discharge in the sympathetic nervous system. I  is 
easy to recognize and empathize with acute pain. We 
wince if we see severe, acute pain and respond with our 
own "sympathetic" discharge.  
 
Chronic Pain: Chronic pain is very different from acute 
pain. It serves no biological purpose. While the suffering 
engendered may be as great as is that in acute pain, it is 
subjectively experienced and objectively displayed in a 
very different way. For reasons not well understood, 
chronic pain is characterized by physical and mental 
withdrawal.  
 
Pain in Children 
 
Until the 1970s, pain in children was ignored in health 
care research. The common assumption was that chil-
dren did not experience pain to the extent that adults o, 
because of the immature nervous system, or that chil-
dren would not remember the pain. Consequently, chil-
dren were often under-medicated or not medicated at all 
for pain. This practice continued until the late 1980s, 
when changes began to occur in pain management in 
infants and children as a result of research, consumer 
demands, and legislation to promote development of 
drugs for these patients. Substantial evidence now i di-
cates not only that children experience pain but tha e 
pain experience may have long-term adverse conse-
quences perception. The misperception that infants have 
immature nervous systems and therefore do not feel pain 
is still common. All nerve pathways necessary for pain 
transmission and perception are present and functioning 
by 24 weeks’ gestation. Research in both animal models 
and human newborns confirms that a lack of analgesia 
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for pain causes “rewiring” in the nerve pathways in-
volved in the transmission of pain. Consequently, an 
infant or child who experiences pain once will have 
greater pain perception during later painful experiences. 
Taddio et al found that babies who did not receive anal-
gesia or anesthesia during circumcision later had greater 
behavioral and physiological disturbances during immu-
nization. 
 
Another common myth is that children do not experi-
ence chronic pain. Indeed, children do experience 
chronic pain syndromes such as:  complex regional pain
syndrome, as well as acute forms of pain related to 
chronic conditions such as sickle cell anemia. They also 
experience various forms of recurrent pain, most com-
monly headache, abdominal pain, back pain, chest pain,
and limb pain. Surgical interruption of a particular tract 
to abolish chronic pain is not usually effective; the pain, 
although initially alleviated, tends to return. Indeed, 
there is often no completely successful treatment for 
these unfortunate patients. 
 
Development of pain apparatus: The neural progres-
sion of pain transmission begins with the development 
of skin and mouth sensory neurons by the end of the 
first 2 wk of gestation. There is a progression in the
growth of the neural apparatus involved in pain trans-
mission throughout fetal development until the appear-
ance of the beginning of the pain inhibitory apparatus, 
starting at approximately 32 week of gestation and con-
tinuing into the newborn period. 
 
Sources of Pain: Repeated heelsticks, indwelling cathe-
ters, necrotizing enterocolitis, nerve injury, thrombo-
phlebitis. Almost all children with a diagnosis of cancer 
will experience pain from illness or a procedure. More 
than 70% suffer from severe pain at some point in their 
illness experience. 
 
Myths about pain in children 
 
Infants cannot feel pain because their nervous system is 
immature. The true situation is that there is considerable 
maturation by 26 weeks of gestation; nociceptive path-
ways to the central nervous system are myelinated by 
about gestation 30 weeks. Descending inhibitory path-
ways develop later than afferent excitatory pathways. 
Extremely pre-term infants can localize and withdraw 
from noxious stimuli. Neonates exhibit behavioral, 
physiological and hormonal responses to pain.  
 
An active or sleeping child is not in pain. The true situa-
tion is that pain may result in “exhausted” sleep. Chil-
dren may read, play or watch TV to distract themselves 
from the pain. Children are particularly good at using 
distraction as coping mechanism. 
 
Children always tell the truth about pain. This may not 
be true because children are scared of injections. 
Younger children may feel that pain is a punishment for 
doing something wrong. Onset of pain may be gradual 
so the child does not realize they have pain until it has 
been alleviated.  Fear of what will happen next. 
 
Children cannot describe and locate their pain. McGrath 
reports children as young as 18 months being able to 
report their pain verbally and localize it. Children as 
young as three years old have used self- report tools  
describe and locate their pain. Children can demonstrate 
on an outline of the body where they hurt without know-
ing the names of the body parts. 
 
Clinical Assessment of Pain  
 
Pain is both a sensory and an emotional experience. I  
older children, the character, location, quality, duration, 
frequency, and intensity of their pain can be assessed. 
Behavior and physiologic signs are useful, but can be 
misleading. A child who is experiencing significant 
chronic pain may play “normally” as a way to distrac  
attention from pain. This coping behavior is sometis 
misinterpreted as evidence of the child “faking” pain t 
other times.  Investigators have devised a range of be-
havioral distress scales for infants and young children, 
mostly emphasizing the patient's facial expressions, cry-
ing, and body movement.  In assessing a child’s pain, a 
measuring tool must take into account: child’s age, cog-
nitive level, type of pain, situation in which the pain is 
occurring, no single measure is useful for all children 
with all types of pain.  
 
Behavioral Observational Scales  
 
The primary method of pain assessment for infants, chil-
dren aged less than three years, and developmentally 
disabled patients.  
CRIES: Assesses Crying, Oxygen requirement, In        
creased vital signs, facial expression, Sleep 
FLACC: Face, Legs, Activity, Crying, Consolability 
scale has been validated from two months to 
seven years. FLACC uses 0-10 scoring. 
NIPS:  Neonatal Infant Pain Scale 
SUN:   Scale for Use in Newborns 
CHEOPS: Children’s Hospital of Eastern Ontario Scale.   
Intended for children aged one to seven years. 
Faces: Children aged three years and above can rank 
their pain using one of several validated scales 
including the Wong-Baker Faces scale, Bieri-
Modified, and Oucher scale. 
Self-report is the gold standard in the assessment of pain 
intensity. 
Visual pain scale: This includes the colour and other 
analog scales: Horizontal or vertical ruler, on which 
increasing intensity of red signifies more pain. These 
scales are asy to use, are efficient, and offer values of 
pain intensity that can be statistically analyzed to deter-
mine the efficacy of a pain treatment intervention. 
 
Several questionnaires have been developed for children 
with chronic or persistent pain. These include: 
• Varni-Thompson Pediatric Pain Questionnaire. 
•  Children’s Comprehensive Pain Questionnaire. 
• Autonomic measures (e.g., heart rate, blood pres-
sure, heart rate spectral analyses). 
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• Hormonal-metabolic measures. 
 
Interventions For Pain Management 
 
These include non-pharmacological and pharmacologi-
cal interventions. 
Non-pharmacologic interventions: These approaches 
have excellent safety profiles and increasing evidence of 
effectiveness. Adopt a child-centered approach 
(listening to the needs of the child and family) rather 
than a procedure-focused “get-it-over-with” approach. 
Use the least invasive equipment where possible.  En-
sure that the person performing the procedure has appro-
priate technical expertise, or is closely supervised by 
someone who does. Optimize waiting time: too little 
time increases distress but too much time increases n-
ticipatory anxiety. Time required for preparation is child
-specific. Ensure that the development of anticipatory 
anxiety is prevented as far as possible by maximising 
the intervention to alleviate pain and distress for the first 
procedure. 
 
Area of emphasis for intervention: 
Neonate/ infant- Sensory  Toddler-Sensory 
Preschooler-Sensory/ Behavioral    S c h o o l  A g e -
Sensory/ Behavioral/ Cognitive 
Adolescent-Sensory/ Behavioral/ Cognitive 
 
• Techniques: Neonate/ infant: Positioning, swad-
dling, rocking/ cuddling, touch/ massage, dim light-
ing, visual distraction, sucking and sucrose/ water 
solution on pacifier. 
•  Toddler: Distraction devices (toys/ music/ videos, 
security object (blanket/ toy/ stuffed animal), paci-
fier, touch/ massage, hugging/ holding, Imagery, 
play, positioning, heat/ cold application. 
• School age: Heat/ cold application, touch/ massage, 
play therapy, humour, distraction devices (music/
videos/breathing techniques), positioning, exercise, 
hugging/ holding, imagery. 
• Adolescent:  Hypnotherapy, heat/ cold application, 
relaxation techniques, humour, breathing tech-
niques, prayers, distraction (especially music/ vid-
eos), yoga. 
 
Pharmacological Management: The general principles 
of newborn physiology and its effects on the pharmacol-
ogy should be taken into consideration. Most analgesics 
are conjugated in the liver hepatic enzyme systems, 
which mature at varying rates over the first one to six 
months of life. The glomerular filtration rates are dimin-
ished in the first week of life, and newborns have a 
higher percentage of body weight as water and less as 
fat compared with older patients. Newborns, and espe-
cially premature infants, have diminished ventilatory 
responses to hypoxemia and hypercarbia. 
 
Pain management with pharmacological intervention 
involves understanding of the pediatric doses, use of the 
analgesic ladder, keep the approach simple and consis-
tent, use the oral and sublingual route in most cases, 
work with the child and the family to choose medication 
to ensure compliance. 
Commonly used analgesics include acetaminophen, 
NSAID (e.g. diclofenac, ibuprofen), codeine, pentazo-
cine and morphine. 
 
Acetaminophen 10–15 mg/kg per oral q4 hourly. Has 
anti-inflammatory action; no antiplatelet or gastric ef-
fects; toxic dosing can produce hepatic failure.  
Aspirin 10–15 mg/kg per oral q4 hourly. Anti-
inflammatory effects; prolonged antiplatelet effects; can 
cause gastritis; risk of Reye syndrome.  
Opioids are administered for moderate and severe pain.
 
Routes: oral, rectal, oral transmucosal, transdermal, 
intranasal, intravenous, epidural, intrathecal, subcutane-
ous, or intramuscular route. 
 
Practical Aspects of Prescribing Opioids: Morphine is 
typically regarded as the first choice for severe pain. The 
right dose is the dose that relieves pain with a good mar-
gin of safety. Dosing should be titrated and indiviual-
ized. There is no “right” dose for everyone. Anticipate 
and treat peripheral side effects, including constipation, 
nausea, and itching. Give doses at sufficient frequency 
to prevent the return of severe pain before the next dose. 
After opioid dosing for more than one week, it should be 
tapered gradually to avoid withdrawal symptoms. 
 
Tolerance: refers to decreasing effect on continued ad-
ministration of a drug or the need for increased dosing to 
achieve the same effect. 
 
Dependence: refers to the need for continued opioid 
dosing to prevent withdrawal symptoms (irritability, 
agitation, autonomic arousal, nasal congestion, piloerec-
tion, diarrhea and/or jitteriness; and in neonates yawn-
ing. 
 
Addiction:  refers to psychological craving with compul-
sive drug-seeking behavior. Opioid under-dosing does 
not prevent addiction and may increase drug-seeking 
behavior for relief of pain; good pain relief takes the 
focus off opioids. 
 
PRN versus Regular dosing: It has been shown that 
when analgesic medications are given regularly on a 
schedule, the cumulative dose of analgesia required is 
less than that required when pain medications are given 
prn. The reason is that by the time the patient asks for 
the medication, a higher dose is required to alleviat  the 
pain. 
 
Patient controlled analgesia (PCA)/ Nurse controlled 
analgesia (NCA): Children as young as six to seven 
years of age can independently use the PCA pump to 
provide good pain relief. Patient controlled analgesia 
refers to intravenous administration of analgesia, using a 
programmed pump. The pump may be programmed to 
give continuous medication with the ability for the pa-
tient to self-administer bolus increases, or it may be pro-
grammed only for bolus administrations. It is pro-
grammed to permit a maximum dose, so as not to cause 
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over sedation. 
Psychothropic Medications in Pain Management: 
Children and adolescents with chronic pain with no 
identified cause, as well as those with identified medical 
causes of pain, have significantly more psychiatric dis-
orders than healthy children. These include depression, 
sleep anxiety disorders, including generalized anxiety 
disorder, separation anxiety, post-traumatic stress di or-
der and panic disorder. This increase in co-morbid psy-
chiatric disorders may be explained by the disruption of 
the serotonergic and noradrenergic systems that are the 
common pathways in both pain disorders and psychiat-
ric disorders. Psychotropic medications should be us d 
with caution. Allow the child to participate effectively in 
therapies and return to normal activity as soon as possi-
ble. Side effects should be specifically addressed 
 
Antidepressant Medications: Useful in adults with 
chronic pain, including neuropathic pain, headaches, and 
rheumatoid arthritis. However, limited clinical trials 
have been done in children. Tricyclic anti-depressants 
(TCAs) have been most studied with relation to chronic 
pain in children and have been found effective in pain 
relief for symptoms including neuropathic pain, func-
tional abdominal pain, and migraine prophylaxis. It is 
effective in the treatment of sleep disorders, which fre-
quently accompany pediatric pain syndromes.  
 
Side effects: Cardiotoxicity, discontinuation syndrome 
including agitation, sleep disturbances, appetite changes, 
and gastrointestinal symptoms. These medications 
should be tapered slowly. 
 
Serotonin Reuptake Inhibitors (SSRIs): Have demon-
strated modest improvement in the treatment of a variety 
of pain syndromes in adults, leading to a supposition 
that noradrenergic pathways are more significant in the 
treatment of pain than serotonergic pathways. SSRIs are 
indicated when symptoms of depressive or anxiety dis-
orders are prominent. These medications have a less 
severe side effect profile than TCAs, with common side 
effects largely transient. These include gastrointestinal 
symptoms. They should also be tapered over a week 
course. 
 
Anticonvulsants: Traditional anticonvulsants, such as 
carbamazepine and valproic acid, are believed to relieve 
chronic pain by blocking calcium channels at the cellu-
lar level and suppressing the hypersensitive sensory fi-
bers without affecting normal nerve conduction. Anti-
convulsants are useful in patients with mood disorders 
and neuropathic pain. 
 
Benzodiazepines: Benzodiazepines are anxiolytic medi-
cations that have anticonvulsant and muscle relaxant 
effects. Clonazepam, a long-acting benzodiazepine, has 
demonstrated efficacy in neuropathic pain. These medi-
cations are most appropriate in acute situations because 
dependence, tolerance, and withdrawal may occur with
prolonged use. These medications are most appropriate 
in acute situations because dependence, tolerance, d 
withdrawal may occur with prolonged use. 
 
Antipsychotics: Low doses of antipsychotic medica-
tions are often used to address the severe anxiety and 
agitation frequently associated with chronic pain in 
youth. Adverse events associated may be severe.  
 
Responsibility of the Paediatrician 
 
Become knowledgeable about pediatric pain manage-
ment principles. 
• Provide a calm environment for painful procedures. 
• Use appropriate assessment tools and techniques. 
• Anticipate painful experiences.  
• Use a multimodal approach (pharmacologic, cogni-
tive, behavioral, and physical) to pain management.  
• Use a multidisciplinary approach when possible.  
• Involve families in creating solutions for their 
child’s pain. 
 
Institutional Responsibilities: The institutional process 
of acute pain management begins with the affirmation 
that children should have access to the best level of pain 
relief that may be safely provided. 
 
Pain relief, a privilege or a right? 
 
The fundamental principle of responsible medical care is 
not “do not hurt” but “do no harm”. Harm occurs when 
the amount of hurt or suffering is greater than necessary 
to achieve the intended benefit.  
The assessment and treatment of pain in children ar 
important parts of pediatric practice, and failure to pro-
vide adequate control of pain amounts to substandard 
and unethical medical practice. 
 
Nursing Management of Pain 
 
Pain is an unpleasant sensory or emotional experience 
associated with actual or potential tissue damage, or 
described in terms of such damage. Pain is always sub-
jective. It helps a child avoid more injury by warning 
him of the presence of a harmful thing.  
 
Signs and symptoms of pains: Pain may be known by 
observing behavioral changes, expression by verbal or 
visible discomfort such as crying, agitation, tachycardia, 
hypertension, and tachypnea. Not changing position 
very often to avoid the pain or positioning ones’ body in 
a way that it will not hurt. Weight loss may occur due to 
poor feeding, restlessness, they are not comfortable, nd 
move around a lot due to pain. The child tends to pull 
the part of his body that is hurting away from touch or 
gets upset at being touched. Sleeps more or sleeps ss 
than usual. Self focusing and touches, tugs, rubs, or 
massages the part of his body that is painful. There is 
educed interaction with other siblings and people. Hy-
perthermia or hypothermia 
 
Pain scale: These include  
 
Body outline tool: A child marks an X or colors the 
painful area on a drawing of a child's body. Different 
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colors can be used to quantify the pain. 
Colored analog scale: Colors are assigned for most or 
worst hurt, a little less hurt, or no hurt. A number can 
also be placed on each color. 
 
Facial Expression Pain Scale: This scale consists of 5 
to 9 faces, ranging from happy or neutral (no pain) to 
sad or distressed. Scales may vary in the number of 
faces, but six faces are usually used. A child may tell 
how much pain he has by pointing on the face he 
chooses. Scores are easily compared to a visual analog 
pain scale. 
 
Oucher scale: A vertical numerical scale from 10 to 100 
for children who can count. The numbers have a corre-
sponding vertical picture scale of expression of no hurt 
to worse hurt. 
 
Poker chip tool: Four poker chips are used. One chip 
represents a little hurt and four chips is the most hur  a 
child could experience. 
 
Visual analog pain scale: This is a 10 centimeter line 
scale with one end marked no pain and the other end 
worst pain. This method may be used in children as 
young as seven years old. 
  
The Children's Hospital of Eastern Ontario Pain 
Scale (CHEOPS): Is based on observation of child be-
havior by physicians or nurse. The scale assigns a point
score to 6 categories of behavior and the total score is 
supposed to correlate with pain. It’s not too reliable. 
Note: crying can be caused by pain, hunger, frustration, 
restraints or anxiety. 
 
 The objective pain scale combines physiologic and be-
havioral parameter. The ability to calm the child is im-
portant when using this scale. 
 
Pain Management  
Pharmacologic  
 
Non-Steroidal Anti Inflammatory Drugs (NSAIDS) 
eg acetaminophen, ibuprofen: It is used for mild to 
moderate pain control, such as pain coming from a 
pulled tooth. It may also be used in controlling pain fter 
surgery. 
 
Opioid Analgesics: These medicines may include oral 
liquid morphine. It may be taken every 4 to 6 hours 
(including break through dose) for mild to moderate 
pain. Morphine is given to provide longer control of 
pain. 
 
Anesthesia: Anesthesia is numbing medicine to control 
pain and make the child comfortable. This works by 
blocking the pain signals from the nerves eg xylocaine 
in scorpion bites. 
 
Patient controlled analgesia (PCA): A device is used 
to give a child pain medicine e.g. in SCD. This devic  
has an electric pump connected by a tube to an IV line.
The IV tube is placed in a child's vein usually in the 
arm. The child receives medicine from the pump 
through the tube when he is in pain.  
 
Non Pharmacologic Intervention: A few of the most 
useful methods in children are: 
Use of heat or cold compress, distraction (music, video 
games, TV, stories, blowing bubbles, puzzles), relaxa-
tion (breathing exercises, rocking chair), massage (bed
bath, gentle back rub, lotion), rest (dimming lights and 
reducing noise, encouraging sleep), changing position 
(use of pillows, sitting up), imagination (creating stories 
and drawing pictures).  
 
Gathering information about the pain can provide infor-
mation about the extent of the pain. Assess for signs and 
symptoms associated with pain such as fatigue, de-
creased appetite, weight loss, changes in body posture, 
sleep pattern disturbance, anxiety, irritability, restless-
ness, or depression. Perform a comprehensive assess-
ment of pain to include location, characteristics, onset, 
duration, frequency, quality, intensity or severity, and 
precipitating factors of pain. Consider cultural influ-
ences on pain response (e.g., cultural beliefs about pain 
may result in a stoic attitude). Reduce or eliminate f c-
tors that precipitate or increase pain experience (e.g.fear, 
fatigue, monotony, and lack of knowledge). 
 
Teach the use of non pharmacologic techniques (e.g., 
relaxation, guided imagery, music therapy, distraction, 
and massage) before, after, and if possible during pain-
ful activities; before pain occurs or increases; and long 
with other pain relief measures. This can increase the 
release of endorphins and enhance the therapeutic ef-
fects of pain relief medication. Simple relaxation ther-
apy is ingineous with nurses to produce relaxation such 
as yawning, deep breathing, abdominal breathing. Indi-
vidualize the content of relaxation by asking the child 
what the child loves to do when relaxing. 
 
Research shows that the most common reason for unre-
lieved pain is failure to routinely assess pain and pain 
relief. Evaluate the effectiveness of analgesic at regular, 
frequent intervals after each administration and espe-
cially after the initial doses. Ongoing evaluation will 
assist in making necessary adjustments for effectiv pain 
management. Observe for any signs and symptoms of 
adverse reaction effects (e.g., respiratory depression, 
nausea and vomiting, dry mouth, and constipation). 
Documentation facilitates pain management by commu-
nicating effective and non effective pain management 
strategies to the entire health care team. 
Ensure as a nurse that the drug is the: right drug, right 
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